Here Are 5 Impactful Events For Life Sciences Investors!
Recently, the Life Sciences industry has captured the attention of global markets with headline-grabbing discoveries related to weight loss and Alzheimer’s.
From painful experience, we know that failing to track key events can be costly. Examples of events you should look into include:
- Are there any impending regulatory changes in important countries?
- When will earnings of industry leaders be released?
- Will any licenses of patents expire soon?
In this article, we highlight 5 Impactful Events For Life Sciences Investors. Contact us at team@capnote.com to purchase an industry timeline with over 250 events. Use Capnote’s Intelligent Timeline feature to constantly add and track impactful events for companies and industries.
Below are 5 impactful events in the Life Sciences Industry to watch out for if you are an investor or provide financial advice to clients in this sector.
Also Read: See 4 Bullish Signs For Meta From Financial Algorithms
1. Johnson & Johnson Key Patent Expiration.
STELARA is the company’s largest product. It accounted for approximately 12.8% of total revenues in 2023. The United States patent of this drug expired in 2023 and the EU patent will expire in 2024.
According to company management, they do not anticipate the launch of a biosimilar version of STELARA before 1 January 2025 in the United States. This poses a significant risk to company revenue and profitability. Source: Johnson and Johnson 10K, 2023.
2. The FDA Facilitates Broader Adoption of VHP.
In January 2024, the US FDA ruled that Vaporized Hydrogen Peroxide is a safe and establish method of sterilization for medical devices which also aligns with ESG considerations.
Meanwhile, the FDA stated this is part of the agency’s multi-pronged approach to reducing the use of ethylene oxide (EtO) and further supports the agency’s efforts to advance medical device supply chain resiliency. This may present opportunities for producing companies and technologies.
3. The UK Voluntary Pricing Access & Growth Scheme (VPAG) Begins.
VPAG is a 5 year pricing agreement for branded medicine signed by the UK Government and the UK Pharmaceutical Industry Body. It starts on 1 January 2024 and will be in place for 5 years until 31 December 2028.
It is also quite significant and could limit price increases and NHS expenditure on certain medicines. Investors are waiting to see how this will impact pharmaceutical companies.
4. Novo Nordisk’s Ozempic Patent Expiration In China.
Reuter’s reports, “Novo’s patents in China on Ozempic and related drug Wegovy are set to expire in 2026, according to its annual report. Ozempic became the world’s best-selling diabetes drug last year.
Novo’s Ozempic sales in China more than doubled last year to 4.8 billion Danish crowns ($694 million), accounting for 5% of global Ozempic sales of 95.7 billion crowns.
As a result, cheap copies of Ozempic in Asia’s largest market could dampen demand for Wegovy, which Novo plans to launch in China this year.”
5. Carbon Reduction Requirements For NHS Suppliers
The National Health System (NHS) in the U.K. established a goal to achieve to net zero by 2045 for all emissions it can influence in its supply chain.
Starting in April 2023, the NHS requires that all suppliers of goods and services with NHS contracts above GBP 5 million publish a carbon reduction plan for their direct emissions.
Furthermore, Many investors and financial institutions believe this could significantly influence many companies’ long-term prospects and are similarly requesting climate change disclosures from their investments.
Fun With Financial Literacy For Kids
In between creating financial algorithms, the Capnote team had some fun writing a short story to help kids learn about money. What Is Money – A Story For Kids, is the first part of a media series created by Finvar with the aims of promoting financial literacy at younger ages. It’s perfect for parents, educators and caregivers interested in sharing teachable lessons with children in a fun and safe way. It also makes a great gift idea!
